Skip to Content

Clinical Trials Details

GOG 0277

Patient Information

GOG 0277 - A Phase III Randomized Trail of Gemcitabine (NSC#613327 Plus Docetaxel (NSC# 628503) followed By Doxorubicin (NSC#123127) Versus Observation for Uterus Limited, High-Grade Uterine Leiomyosarcoma

Find out more information about clinical trial - GOG 0277

Clinical Trial Categories

  • Uterine Cancer


  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Also in this Section